TMPRSS2
| Transmembrane protease, serine 2 | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||||||
| Symbols | TMPRSS2 ; PP9284; PRSS10 | ||||||||||||
| External IDs | OMIM: 602060 MGI: 1354381 HomoloGene: 4136 ChEMBL: 1795140 GeneCards: TMPRSS2 Gene | ||||||||||||
| EC number | 3.4.21.- | ||||||||||||
| |||||||||||||
| RNA expression pattern | |||||||||||||
 | |||||||||||||
 | |||||||||||||
| More reference expression data | |||||||||||||
| Orthologs | |||||||||||||
| Species | Human | Mouse | |||||||||||
| Entrez | 7113 | 50528 | |||||||||||
| Ensembl | ENSG00000184012 | ENSMUSG00000000385 | |||||||||||
| UniProt | O15393 | Q9JIQ8 | |||||||||||
| RefSeq (mRNA) | NM_001135099 | NM_015775 | |||||||||||
| RefSeq (protein) | NP_001128571 | NP_056590 | |||||||||||
| Location (UCSC) |
Chr 21: 41.46 – 41.53 Mb |
Chr 16: 97.56 – 97.61 Mb | |||||||||||
| PubMed search | |||||||||||||
Transmembrane protease, serine 2 is an enzyme that in humans is encoded by the TMPRSS2 gene.[1][2]
Function
This gene encodes a protein that belongs to the serine protease family. The encoded protein contains a type II transmembrane domain, a receptor class A domain, a scavenger receptor cysteine-rich domain and a protease domain. Serine proteases are known to be involved in many physiological and pathological processes. This gene was demonstrated to be up-regulated by androgenic hormones in prostate cancer cells and down-regulated in androgen-independent prostate cancer tissue. The protease domain of this protein is thought to be cleaved and secreted into cell media after autocleavage. The biological function of this gene is unknown.[2]
ERG gene fusion
TMPRSS2 protein's function in prostate carcinogenesis relies on overexpression of ETS transcription factors, such as ERG and ETV1, through gene fusion. TMPRSS2-ERG fusion gene is the most frequent, present in 40% - 80% of prostate cancers in humans. ERG overexpression contributes to development of androgen-independence in prostate cancer through disruption of androgen receptor signaling.[3]
References
- ↑ Paoloni-Giacobino A, Chen H, Peitsch MC, Rossier C, Antonarakis SE (Sep 1997). "Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3". Genomics 44 (3): 309–20. doi:10.1006/geno.1997.4845. PMID 9325052.
- 1 2 "Entrez Gene: TMPRSS2 transmembrane protease, serine 2".
- ↑ Yu J, Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, Wang X, Wu L, Li J, Hu M, Gong Y, Cheng H, Laxman B, Vellaichamy A, Shankar S, Li Y, Dhanasekaran SM, Morey R, Barrette T, Lonigro RJ, Tomlins SA, Varambally S, Qin ZS, Chinnaiyan AM (May 2010). "An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression". Cancer Cell 17 (5): 443–54. doi:10.1016/j.ccr.2010.03.018. PMC 2874722. PMID 20478527.
Further reading
- Maruyama K, Sugano S (Jan 1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene 138 (1-2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (Oct 1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene 200 (1-2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Lin B, Ferguson C, White JT, Wang S, Vessella R, True LD, Hood L, Nelson PS (Sep 1999). "Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2". Cancer Research 59 (17): 4180–4. PMID 10485450.
- Vaarala MH, Porvari KS, Kellokumpu S, Kyllönen AP, Vihko PT (Jan 2001). "Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues". The Journal of Pathology 193 (1): 134–40. doi:10.1002/1096-9896(2000)9999:9999<::AID-PATH743>3.0.CO;2-T. PMID 11169526.
- Afar DE, Vivanco I, Hubert RS, Kuo J, Chen E, Saffran DC, Raitano AB, Jakobovits A (Feb 2001). "Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia". Cancer Research 61 (4): 1686–92. PMID 11245484.
- Jacquinet E, Rao NV, Rao GV, Zhengming W, Albertine KH, Hoidal JR (May 2001). "Cloning and characterization of the cDNA and gene for human epitheliasin". European Journal of Biochemistry / FEBS 268 (9): 2687–99. doi:10.1046/j.1432-1327.2001.02165.x. PMID 11322890.
- Teng DH, Chen Y, Lian L, Ha PC, Tavtigian SV, Wong AK (Jun 2001). "Mutation analyses of 268 candidate genes in human tumor cell lines". Genomics 74 (3): 352–64. doi:10.1006/geno.2001.6551. PMID 11414763.
- Wilson S, Greer B, Hooper J, Zijlstra A, Walker B, Quigley J, Hawthorne S (Jun 2005). "The membrane-anchored serine protease, TMPRSS2, activates PAR-2 in prostate cancer cells". The Biochemical Journal 388 (Pt 3): 967–72. doi:10.1042/BJ20041066. PMC 1183478. PMID 15537383.
- Soller MJ, Isaksson M, Elfving P, Soller W, Lundgren R, Panagopoulos I (Jul 2006). "Confirmation of the high frequency of the TMPRSS2/ERG fusion gene in prostate cancer". Genes, Chromosomes & Cancer 45 (7): 717–9. doi:10.1002/gcc.20329. PMID 16575875.
- Tomlins SA, Mehra R, Rhodes DR, Smith LR, Roulston D, Helgeson BE, Cao X, Wei JT, Rubin MA, Shah RB, Chinnaiyan AM (Apr 2006). "TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer". Cancer Research 66 (7): 3396–400. doi:10.1158/0008-5472.CAN-06-0168. PMID 16585160.
- Yoshimoto M, Joshua AM, Chilton-Macneill S, Bayani J, Selvarajah S, Evans AJ, Zielenska M, Squire JA (Jun 2006). "Three-color FISH analysis of TMPRSS2/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement". Neoplasia 8 (6): 465–9. doi:10.1593/neo.06283. PMC 1601467. PMID 16820092.
- Böttcher E, Matrosovich T, Beyerle M, Klenk HD, Garten W, Matrosovich M (Oct 2006). "Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium". Journal of Virology 80 (19): 9896–8. doi:10.1128/JVI.01118-06. PMC 1617224. PMID 16973594.
- Cerveira N, Ribeiro FR, Peixoto A, Costa V, Henrique R, Jerónimo C, Teixeira MR (Oct 2006). "TMPRSS2-ERG gene fusion causing ERG overexpression precedes chromosome copy number changes in prostate carcinomas and paired HGPIN lesions". Neoplasia 8 (10): 826–32. doi:10.1593/neo.06427. PMC 1715930. PMID 17032499.
- Yoo NJ, Lee JW, Lee SH (Mar 2007). "Absence of fusion of TMPRSS2 and ETS transcription factor genes in gastric and colorectal carcinomas". Apmis 115 (3): 252–3. doi:10.1111/j.1600-0463.2007.apm_652.x. PMID 17367471.
- Winnes M, Lissbrant E, Damber JE, Stenman G (May 2007). "Molecular genetic analyses of the TMPRSS2-ERG and TMPRSS2-ETV1 gene fusions in 50 cases of prostate cancer". Oncology Reports 17 (5): 1033–6. doi:10.3892/or.17.5.1033. PMID 17390040.
- Tu JJ, Rohan S, Kao J, Kitabayashi N, Mathew S, Chen YT (Sep 2007). "Gene fusions between TMPRSS2 and ETS family genes in prostate cancer: frequency and transcript variant analysis by RT-PCR and FISH on paraffin-embedded tissues". Modern Pathology 20 (9): 921–8. doi:10.1038/modpathol.3800903. PMID 17632455.
This article is issued from Wikipedia - version of the Saturday, December 26, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.